Surajit Chakrabartty, CFO - MedGenome

Surajit Chakrabartty, CFO - MedGenome
Published on
1 min read


As India continues to prioritize healthcare and innovation to drive its long-term development goals, we remain optimistic that the upcoming budget will recognize the transformative role genomics can play in revolutionizing diagnosis and improving healthcare outcomes. Over the next 5-7 years, we anticipate genomic testing becoming an integral part of routine healthcare, driving advancements in early disease detection and personalized medicine. To fully unlock the potential of genomics, we hope the budget will allocate substantial funding for research and infrastructure development in genomics, accelerating the adoption of cutting-edge technologies and ensuring affordable and equitable access to diagnostics across all demographics.

Strengthening public-private partnerships, offering tax incentives for biotech startups, and cultivating a strong policy framework will allow groundbreaking innovations to scale and reach every corner of the country helping tackle some of India’s most urgent healthcare challenges.

To position India as a global leader in personalized healthcare, it is imperative to enhance the infrastructure for precision medicine and foster collaboration across sectors. These initiatives will not only lead to better patient outcomes through timely and targeted interventions but also establish India as a hub for multi-omics led diagnostics, improving the health of millions while driving economic growth.

Related Stories

No stories found.
Voice Of HealthCare
vohnetwork.com